Phenotypic and Functional Characterization of Bovine Adipose-Derived Mesenchymal Stromal Cells

• Published in: Animals (Basel) Vol. 14; no. 9; p. 1292
• Main Authors: Maldonado, Vitali V, Pokharel, Sriya, Powell, Jeremy G, Samsonraj, Rebekah M
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.05.2024
• Subjects: Adipose tissues; Body fat; Bone marrow; bovine mesenchymal stem cells; Cattle; cattle industry; Cell culture; cellular therapy; Control systems; Cytokines; Interferon; Livestock industry; Penicillin; Peptides; phenotypic characterization; regenerative medicine; Respiratory diseases; Stem cells; Transplantation; United States > US; phenotypic characterization; cellular therapy; bovine mesenchymal stem cells; regenerative medicine; cattle industry
• ISSN: 2076-2615; 2076-2615
• DOI: 10.3390/ani14091292

Mesenchymal stem cells (MSCs) are increasingly trialed in cellular therapy applications in humans. They can also be applied to treat a range of diseases in animals, particularly in cattle to combat inflammatory conditions and aging-associated degenerative disorders. We sought to demonstrate the feasibility of obtaining MSCs from adipose tissue and characterizing them using established assays. Bovine adipose MSCs (BvAdMSCs) were isolated using in-house optimized tissue digestion protocols and characterized by performing a colony formation assay, cell growth assessments, cell surface marker analysis by immunocytochemistry and flow cytometry, osteogenic and adipogenic differentiation, and secretion of indoleamine 2,3-dioxygenease (IDO). Our results demonstrate the feasibility of successful MSC isolation and culture expansion from bovine adipose tissues with characteristic features of colony formation, in vitro multilineage differentiation into osteogenic and adipogenic lineages, and cell surface marker expression of CD105, CD73, CD90, CD44, and CD166 with negative expression of CD45. BvAdMSCs secreted significant amounts of IDO with or without interferon-gamma stimulation, indicating ability for immunomodulation. We report a viable approach to obtaining autologous adipose-derived MSCs that can be applied as potential adjuvant cell therapy for tissue repair and regeneration in cattle. Our methodology can be utilized by veterinary cell therapy labs for preparing MSCs for disease management in cattle.